Today, the Food and Drug Authority authorized the use of the British “AstraZeneca” vaccine against the Coronavirus (Covid-19), which was developed by the company in cooperation with the University of Oxford, and the “Authority” approved the use of the vaccine and allowed its import based on the data provided to it, which has been reviewed with all its details according to Accurate scientific methodology, and accordingly, the health authorities in the Kingdom will initiate procedures for using the "AstraZeneca" vaccine in accordance with the standards and requirements for that. The "Authority" will also analyze samples from each incoming shipment of the vaccine before using it.

The "authority" indicated that it is working according to a scientific mechanism to approve the use of vaccines, as it studies the safety, efficacy and quality of vaccines through clinical trials and studies, and scientific data that show the quality of manufacturing and product stability, in addition to verifying the manufacturing stages and the factory's commitment to applying the foundations of good pharmaceutical manufacturing. (GMP) according to international standards in the pharmaceutical industry, as the authority’s procedures included holding several meetings with experts and specialized scientists - local and international - to take their views, in addition to meeting with the manufacturer and its representatives to answer the inquiries submitted by the Authority and the scientific advisory team for infectious diseases emanating from Scientific Advisory Committee for Clinical Studies.